Stock Update: Allergan Inc (NYSE:AGN) – Independent Baylor University Study Showcases Economic Impact of Allergan on Waco and Central Texas Economies

[PR Newswire] – WACO, Texas, Jan. 29, 2016 /PRNewswire/ — A new, independent study from the Baylor University Center for Business & Economic Research found that Allergan’s Waco operations generated a combined economic impact on Waco area income of $263 million and an aggregate impact on total spending of $406 million in the Central Texas economy in 2015. The economic impact was a direct result of the Company’s strong employment and labor force earnings at its Waco facility, with employment increasing 28% and its labor force earnings increasing 39% in the period between 2010 and 2015. The study, titled “The Economic Impact of Allergan on the Central Texas Economy ,” was conducted and developed by Tom Kelly, Ph.D., Baylor’s Center for Business & Economic Research in Baylor University’s Hankamer School of Business. Read more on this. Allergan plc (AGN) , valued at $110.80B, started trading this morning at $286.30. Looking at the equity, the company’s one day range is $278.91 to $286.95 with a one year range of $237.50 to $340.34. Priced at 19.09x this year’s forecasted earnings, AGN shares are relatively expensive compared to the industry ’s -1.49x forward p/e ratio. And for income investors, the company pays shareholders $0.20 per share annually in dividends, yielding 0.10%. Consensus earnings for the current quarter by the 13 sell-side analysts covering the stock is an estimate of $3.36 per share, which would be $0.55 worse than the year-ago quarter and a $0.05 sequential increase. Furthermore, our analysis shows the full-year EPS estimate to be $15.43, which would be a $1.45 better when compared to the last year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $4.20 Billion. If realized, that would be a 3.45% increase over the year-ago quarter. More recently, Mizuho Initiated AGN at Buy (Oct 9, 2015). Previously, Nomura Initiated AGN at to Buy. With the above information in mind, readers should note that the average price target is $367.40, which is 28.33% above where the stock opened this morning. See more in (NYSE:AGN) Similar Articles: Stock Update: Allergan Inc (NYSE:AGN) – Allergan to Report Fourth Quarter and Full-Year 2015 Earnings and Host Conference Call and Webcast Stock Update: Allergan Inc (NYSE:AGN) – Allergan and Pfizer to Present at 34th Annual J.P. Morgan Healthcare Conference Company Update: Allergan Inc (NYSE:AGN) – Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215